Meadow Creek Investment Management LLC cut its holdings in shares of Express Scripts Holding (NASDAQ:ESRX) by 3.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,078,392 shares of the company’s stock after selling 37,996 shares during the quarter. Express Scripts comprises approximately 1.7% of Meadow Creek Investment Management LLC’s investment portfolio, making the stock its 10th biggest position. Meadow Creek Investment Management LLC owned 0.19% of Express Scripts worth $80,491,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in ESRX. Van ECK Associates Corp boosted its holdings in Express Scripts by 5.1% during the 3rd quarter. Van ECK Associates Corp now owns 506,511 shares of the company’s stock valued at $32,072,000 after acquiring an additional 24,728 shares during the period. Victory Capital Management Inc. boosted its holdings in Express Scripts by 12.5% during the 3rd quarter. Victory Capital Management Inc. now owns 35,421 shares of the company’s stock valued at $2,243,000 after acquiring an additional 3,940 shares during the period. LMR Partners LLP purchased a new position in Express Scripts during the 3rd quarter valued at about $3,230,000. Polianta Ltd boosted its holdings in Express Scripts by 38.9% during the 4th quarter. Polianta Ltd now owns 20,700 shares of the company’s stock valued at $1,545,000 after acquiring an additional 5,800 shares during the period. Finally, Zeke Capital Advisors LLC boosted its holdings in Express Scripts by 85.4% during the 3rd quarter. Zeke Capital Advisors LLC now owns 12,347 shares of the company’s stock valued at $782,000 after acquiring an additional 5,688 shares during the period. Institutional investors and hedge funds own 89.08% of the company’s stock.
A number of equities research analysts have issued reports on the company. William Blair lowered Express Scripts from an “outperform” rating to a “market perform” rating in a research report on Thursday, March 8th. Mizuho set a $96.00 price target on Express Scripts and gave the company a “hold” rating in a research report on Thursday, March 8th. Sanford C. Bernstein raised Express Scripts from an “underperform” rating to a “market perform” rating in a research report on Monday. Zacks Investment Research raised Express Scripts from a “hold” rating to a “buy” rating and set a $84.00 price target on the stock in a research report on Tuesday, March 6th. Finally, Barclays assumed coverage on Express Scripts in a research report on Thursday, March 8th. They issued an “equal weight” rating and a $84.00 price target on the stock. Three research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $81.97.
Shares of Express Scripts Holding (NASDAQ ESRX) opened at $77.00 on Wednesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.55 and a current ratio of 0.67. Express Scripts Holding has a 12-month low of $55.80 and a 12-month high of $85.07. The firm has a market capitalization of $43,220.00, a PE ratio of 9.95, a PEG ratio of 0.96 and a beta of 0.94.
Express Scripts (NASDAQ:ESRX) last issued its earnings results on Tuesday, February 27th. The company reported $2.16 earnings per share for the quarter, topping the consensus estimate of $2.09 by $0.07. Express Scripts had a return on equity of 25.19% and a net margin of 4.51%. The business had revenue of $25.38 billion for the quarter, compared to analyst estimates of $25.07 billion. During the same quarter last year, the company earned $1.88 EPS. The business’s quarterly revenue was up 2.1% on a year-over-year basis. research analysts forecast that Express Scripts Holding will post 9.35 earnings per share for the current fiscal year.
Express Scripts declared that its board has approved a stock repurchase program on Monday, December 18th that permits the company to buyback 45,000,000 outstanding shares. This buyback authorization permits the company to buy shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.